शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSERoopa Industries Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 14 Nov, 2025 · 19:06 IST

Submission of Unaudited Financial Results for the quarter and half year ended 30 September 2025

EBITDA margin compressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.3%Reaction day
₹49.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-3.9% vs market
Pharmaceuticals peers, median of 157sector+0.1%-3.4% vs sector

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.3+0.6-3.9+0.1-3.4
Next day
-3.1-0.2-2.8-0.7-2.4
2d
-0.1-0.4+0.3-1.2+1.1
3d
+2.0-0.7+2.7-0.9+2.9
4d
+2.4-2.2+4.6-2.0+4.4
5d
-5.9-2.8-3.1-3.1-2.8
1w
-1.8-1.4-0.4-2.2+0.4
15d
-15.4-7.0-8.4-4.7-10.7
1m
-6.3-6.1-0.2-5.0-1.3
2m
-4.1-9.2+5.1-7.8+3.7
3m
-0.8-6.8+6.0-9.7+8.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Roopa Industries Limited reported Q2 FY26 revenue from operations of Rs. 28.74 crore, up about 12% YoY from Rs. 25.61 crore, while H1 FY26 revenue rose to Rs. 63.82 crore from Rs. 60.12 crore (~6% YoY growth). However, profit after tax fell — Q2 PAT declined to Rs. 46.42 lakh from Rs. 58.27 lakh YoY, and H1 PAT slipped to Rs. 74.76 lakh from Rs. 85.64 lakh. EPS for Q2 stood at Rs. 0.59 versus Rs. 0.74 a year earlier. Finance costs remained elevated at Rs. 83.35 lakh for the quarter (about 2.9% of revenue), pressuring margins. The auditor flagged a fire accident at the company's Patancheru plant on November 3, 2025, which caused loss of inventory; the company is assessing the actual value to submit an insurance claim.

Likely market impact

Mixed results — top-line growth but bottom-line contraction point to margin pressure and high finance costs eroding earnings. The post-period fire at the Patancheru plant is a material event that may weigh on Q3 FY26 results depending on insurance recovery and operational disruption.